1. Apoptosis
  2. Thymidylate Synthase

Thymidylate Synthase

Thymidylate synthase (TS) is an E2F1-regulated enzyme that is essential for DNA synthesis and repair. Thymidylate synthase is an essential S phase enzyme required for DNA synthesis. Thymidylate synthase plays a central role in the biosynthesis of thymidylate, an essential precursor for DNA synthesis.

Thymidylate synthase catalyzes the reductive methylation of 2′-deoxyuridine 5-monophosphate (dUMP) by transfer of a methylene group from a cofactor, CH2H4 folate, to generate deoxythymidine-5′-monophoshate (dTMP). dTMP is further phosphorylated to the triphosphate state (dTTP), which is a direct precursor for DNA synthesis. Since the TS catalyzed reaction is the sole intracellular de novo source of dTMP, the inhibition of TS results in the cessation of cellular proliferation and growth.

Thymidylate synthase protein and mRNA levels are elevated in many human cancers, and high TS levels have been correlated with poor prognosis in patients with colorectal, breast, cervical, bladder, kidney, and non-small cell lung cancers.

Thymidylate Synthase Related Products (4):

Cat. No. Product Name Effect Purity
  • HY-10821
    Raltitrexed Inhibitor 99.21%
    Raltitrexed is an inhibitor of thymidylate synthase and an antimetabolite drug used for cancer treatment.
  • HY-A0061
    Trifluorothymidine Inhibitor 99.69%
    Trifluorothymidine (TFT) and is an inhibitor of thymidine phosphorylase. TFT also inhibits thymidylate synthase (TS), a rate-limiting enzyme of DNA biosynthesis, and is incorporated into DNA.
  • HY-16478
    TAS-102 Inhibitor 99.50%
    TAS-102 is a novel oral combination drug that consists of an antineoplastic thymidine-based nucleoside analog, trifluorothymidine, and a potent thymidine phosphorylase inhibitor, tipiracil, in a 1:0.5 molar ratio.
  • HY-A0063A
    Tipiracil Inhibitor 99.87%
    Tipiracil is a thymidine phosphorylase (TPase) inhibitor.